Silke Gillessen Sommer

29PUBLICATIONS
264CO-AUTHORS
Predictive and prognostic markersToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 28, 2026
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

|Sep 15, 2026
Intratumoral Human Papillomavirus in Advanced Prostate Cancer: Systematic Review, Meta-Analysis, and Real-World Evidence from the Largest Cohort to Date.

|Aug 27, 2026
Imaging and Clinical Correlates of [177Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Dec 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi, Martino Pedrani, Amos Colombo

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

Pageof 5

Frequent Collaborators

9 joint publications

Ricardo Pereira Mestre

6 joint publications

Matthew R Sydes

5 joint publications

Christopher Sweeney

5 joint publications

Martino Pedrani